BAP1 as a guardian of genome stability: implications in human cancer

被引:21
|
作者
Kwon, Jongbum [1 ]
Lee, Daye [1 ]
Lee, Shin-Ai [1 ,2 ]
机构
[1] Ewha Womans Univ, Dept Life Sci, 52 Ewhayeodae Gil, Seoul 03760, South Korea
[2] Natl Canc Inst, Ctr Canc Res, Lab Genitourinary Canc Pathogenesis, Bldg 37,Room 1068, Bethesda, MD 20892 USA
来源
EXPERIMENTAL AND MOLECULAR MEDICINE | 2023年 / 55卷 / 04期
基金
新加坡国家研究基金会;
关键词
NUCLEOTIDE EXCISION-REPAIR; PREVENTS CHROMOSOME INSTABILITY; DNA-DAMAGE RECOGNITION; TUMOR-SUPPRESSOR BAP1; HISTONE H2A; BRCA1-ASSOCIATED PROTEIN-1; MUTATIONS PREDISPOSE; DEUBIQUITINASE BAP1; UBIQUITIN HYDROLASE; REPLICATION STRESS;
D O I
10.1038/s12276-023-00979-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BAP1 is a ubiquitin C-terminal hydrolase domain-containing deubiquitinase with a wide array of biological activities. Studies in which advanced sequencing technologies were used have uncovered a link between BAP1 and human cancer. Somatic and germline mutations of the BAP1 gene have been identified in multiple human cancers, with a particularly high frequency in mesothelioma, uveal melanoma and clear cell renal cell carcinoma. BAP1 cancer syndrome highlights that all carriers of inherited BAP1-inactivating mutations develop at least one and often multiple cancers with high penetrance during their lifetime. These findings, together with substantial evidence indicating the involvement of BAP1 in many cancer-related biological activities, strongly suggest that BAP1 functions as a tumor suppressor. Nonetheless, the mechanisms that account for the tumor suppressor function of BAP1 have only begun to be elucidated. Recently, the roles of BAP1 in genome stability and apoptosis have drawn considerable attention, and they are compelling candidates for key mechanistic factors. In this review, we focus on genome stability and summarize the details of the cellular and molecular functions of BAP1 in DNA repair and replication, which are crucial for genome integrity, and discuss the implications for BAP1-associated cancer and relevant therapeutic strategies. We also highlight some unresolved issues and potential future research directions. Cancer: Investigating a genome-guarding protein A protein called BAP1, which removes tags marking proteins for degradation, is an important guardian of genome stability, and understanding its function may help in developing cancer therapies. People with mutations that inactivate BAP1 function always develop at least one and often multiple cancers, but specifically how BAP1 mutations cause cancer is not well understood. Jongbum Kwon and co-workers at Ewha Womans University in Seoul, South Korea, have reviewed how BAP1 functions, focusing on DNA repair. The authors report that BAP1 is crucial for repair of large DNA lesions, such as those caused by UV damage, and plays key roles in DNA replication, chromosome segregation, and disposal of cells with damaged DNA. These activities make BAP1 a powerful tumor suppressor, and improving our understanding of its mechanisms could point the way to new cancer treatments.
引用
收藏
页码:745 / 754
页数:10
相关论文
共 50 条
  • [21] Expanded detection and impact of BAP1 alterations in cancer
    Sturgill, Ian R.
    Raab, Jesse R.
    Hoadley, Katherine A.
    NAR CANCER, 2024, 6 (04):
  • [22] Research Progress of BAP1 in Structure, Function, and Cancer
    Lu, Wei-Tao
    Li, Meng-Ru
    Yang, Yi-Bo
    Sun, Yan-Yan
    Dong, Chun-Ming
    PROTEIN AND PEPTIDE LETTERS, 2023, 30 (07): : 552 - 561
  • [23] BAP1 Loss in Triple Negative Breast Cancer
    Vougiouklakis, Theodore
    Schwartz, Christopher
    Cotzia, Paolo
    Snuderl, Matija
    Jour, George
    Darvishian, Farbod
    MODERN PATHOLOGY, 2019, 32
  • [24] BAP1 Missense Mutations in Cancer: Friend or Foe?
    Okonska, Agata
    Felley-Bosco, Emanuele
    TRENDS IN CANCER, 2019, 5 (11): : 659 - 662
  • [25] BAP1 in paragangliomas and pheochromocytomas
    Maffeis, V.
    Cappellesso, R.
    Guzzardo, V.
    Guido, M.
    Fassina, A.
    VIRCHOWS ARCHIV, 2017, 471 : S30 - S31
  • [26] BAP1 in solid tumors
    Di Nunno, Vincenzo
    Frega, Giorgio
    Santoni, Matteo
    Gatto, Lidia
    Fiorentino, Michelangelo
    Montironi, Rodolfo
    Battelli, Nicola
    Brandi, Giovanni
    Massari, Francesco
    FUTURE ONCOLOGY, 2019, 15 (18) : 2151 - 2162
  • [27] Rare BAP1 variant of unknown significance (VUS) and analysis of BAP1 codon 146 genomics: Potential germline and therapeutic implications.
    Murphy, Jo-Ellen
    Sadan, Sara
    Lee, Jessica Kim
    Pruski-Clark, Jana
    Sutphen, Rebecca
    McGregor, Kimberly
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [28] Gene of the month: BAP1
    Wang, Ami
    Papneja, Anjali
    Hyrcza, Martin
    Al-Habeeb, Ayman
    Ghazarian, Danny
    JOURNAL OF CLINICAL PATHOLOGY, 2016, 69 (09) : 750 - 753
  • [29] Loss of BAP1 Expression in Basal Cell Carcinomas in Patients With Germline BAP1 Mutations
    Mochel, Mark C.
    Pins, Adriano
    Nose, Vania
    Hoang, Mai P.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (06) : 901 - 904
  • [30] Loss of BAP1 Leads to More YAPing in Pancreatic Cancer
    Brekken, Rolf A.
    CANCER RESEARCH, 2020, 80 (08) : 1624 - 1625